1. Home
  2. PLCE vs ANIX Comparison

PLCE vs ANIX Comparison

Compare PLCE & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Children's Place Inc. (The)

PLCE

Children's Place Inc. (The)

HOLD

Current Price

$3.54

Market Cap

92.8M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.46

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLCE
ANIX
Founded
1969
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.8M
88.8M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
PLCE
ANIX
Price
$3.54
$2.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$3.50
$8.67
AVG Volume (30 Days)
632.5K
100.0K
Earning Date
04-10-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
11.48
12.82
EPS
N/A
N/A
Revenue
N/A
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$2.44
52 Week High
$9.56
$5.46

Technical Indicators

Market Signals
Indicator
PLCE
ANIX
Relative Strength Index (RSI) 49.53 33.67
Support Level $2.90 $2.44
Resistance Level $3.81 $3.13
Average True Range (ATR) 0.42 0.14
MACD 0.01 -0.03
Stochastic Oscillator 17.41 2.56

Price Performance

Historical Comparison
PLCE
ANIX

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: